Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Michaud LB – The epothilones have demonstrated significant potential for addressing the growing therapeutic challenge of taxane resistance, and the ever–increasing pool of information regarding structure–activity relationships of these MSAs will help to optimize microtubule–targeted chemotherapy.

Related Articles

Epothilones in prostate cancer
Urologic Oncology: Seminars and Original Investigations, 11/25/09    Relevance Score: 83%

Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors
Annals of Oncology, 11/04/09    Relevance Score: 80%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address